Home > PJ (current issue) > Pharmaceutical Care Awards

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7459 p11
7 July 2007

This article
Reprint   Photocopy

PDF 140K, Acrobat Reader

Pharmaceutical Care Awards 2006

Pharmacist prescribing improves the care of hypertensive patients

Pharmacist supplementary prescribing hypertension clinic

Pharmaceutical Care Awards

The Pharmaceutical Care Awards 2006 were presented at a celebratory dinner on 29 June 2007 at Apothecaries’ Hall, London. The dinner followed a conference at the Royal Pharmaceutical Society’s headquarters, where the finalists presented their projects to an audience of invited guests. The awards, organised by The Pharmaceutical Journal, are sponsored by GlaxoSmithKline and the Company Chemists’ Association


Allan Wilson, community pharmacy adviser, North Ayrshire Community Health Partnership

Allan Wilson

Allan Wilson

Community pharmacists can monitor and control patients’ blood pressure, sharing patient care and working in partnership with GP practices. That was the conclusion reached by Allan Wilson, a winner of one of the 2006 Pharmaceutical Care Awards.

Mr Wilson’s project was carried out in Largs, Ayrshire, from November 2005 to March 2007. It piloted a Saturday morning community pharmacy supplementary prescribing clinic for patients with hypertension.

Such a clinic was needed because a high proportion of the town’s population commute to work from Monday to Friday and are, therefore, unable to attend their GP practice during the week.

The clinic was designed to identify patients with hypertension, especially among working people, and to target those who had previously been diagnosed but who were not being monitored. Patients with hypertension were initiated on medication by the GP and then referred to the pharmacist who could monitor progress and add in more treatment if required.

The clinic was held on alternate Saturday mornings. The pharmacist used a clinical management plan that was agreed by the GP and the patient to monitor the patient’s progress — joint working was an important aspect of the pilot service. A significant part of each 20-minute consultation with the community pharmacist involved discussing lifestyle changes, including weight management, alcohol intake, exercise, diet and smoking, as well as talking about BP management and choice of antihypertensive medicines.

During the study period, 56 patients paid 228 visits to the clinic, and 41 of them (73 per cent) responded to a satisfaction questionnaire. Of these, 76 per cent were “very satisfied” with the waiting time for a clinic appointment, 71 per cent were “very satisfied” with the clinic venue and 95 per cent were “very satisfied” with the timing of the clinic. Of the 40 patients who answered a question about whether joint working between the GP and pharmacist worked well, all agreed that it had. On a scale of 1 to 6, every respondent gave the service an overall rating of 5 or 6.

At the end of the study, Largs Medical Group commented that it would be keen for the service to continue. As the clinic has become established and awareness of it has grown, referrals have increased and most clinics are now 80 to 100 per cent full. Now, as a result of the patient satisfaction survey, the clinic has expanded and a Friday evening service has started.

Presenting his project, Mr Wilson said: “The clinic breaks new ground because it allows partnership working between GPs and pharmacists within a community pharmacy setting. It improves choices for patients and enables a more flexible working approach within primary care in the NHS.” In addition, he said, it allows pharmacists to use their skills and professionalism to the full.

Back to Top


©The Pharmaceutical Journal